Cyber Monday Deal: Up to 60% off InvestingProCLAIM SALE

Gold Down on Vaccine Progress, Stronger Dollar

Published 19/11/2020, 03:08 pm
© Reuters.
XAU/USD
-
PFE
-
DX
-
GC
-
BNTX
-

By Adam Claringbull

Investing.com – Gold was down on Thursday morning in Asia as Pfizer Inc (NYSE:PFE) announced safety data to advance its vaccine to the U.S. Food and Drug Administration (FDA) approval stage and the dollar firmed.

Gold futures were down 0.44% at $1,865.65 by 12:21 PM ET (4:21 AM GMT). The dollar was up on Thursday morning.

A strengthening greenback has helped diminish appetite for gold, with the dollar rising as investors move from stocks to the more risk-averse asset. A stronger dollar makes gold more expensive in other currencies.

Adding to the downward pressure on the yellow metal is news from the Pfizer/BioNTech (F:22UAy) vaccine team that they have sufficient safety data to advance their vaccine candidate to the U.S FDA for emergency use approval within days.

"(Vaccines) seem to be progressing quickly and there are several others also in the pipeline ... that should help the global economy recovery and be net bearish for gold. But in the meantime, the fact that we're not out of the woods yet and need more stimulus seems to be offering some support," ED&F Man Capital Markets analyst Edward Meir told Reuters.

The vaccine news helped counteract the upward price driver of the ever-growing COVID-19 pandemic, as it brings some medium- to long-term positivity to global markets and reduces the appetite for the safe-haven metal in the longer term.

"The rollout of positive vaccine developments is reducing gold's lure as a safe-haven. (Although) it still seems to be in a trading range, the big moves up seem to be finished for now,” Meir added.

Despite the bearish outlook, there is still plenty of impetus pushing the previous metal up. The COVID-19 pandemic is worsening rapidly, especially in the economic powerhouse regions of the U.S. and Europe; global cases have now reached over 56 million, with the U.S. accounting for nearly one fifth of them, according to Johns Hopkins University data. Europe, too, is experiencing a rise in cases not seen since the first wave, leading to large-scale lockdowns on public activity, and hence to strongly weakened economic activity.

The U.K. and the E.U. are fast running out of time to reach a trade deal before the transition period for the U.K. leaving the economic bloc expires on Jan. 1, 2021. Talks appear to still be deadlocked over multiple issues.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.